Doxercalciferol

Spécifications

54573-75-0Numéro CAS

643-005-9Numéro CE

trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diolNom IUPAC

C28H44O2Formule chimique

412.6 g/molMasse molaire

Doxercalciferol; 54573-75-0; Hectorol; 1-Hydroxyergocalciferol; 1alpha-Hydroxyergocalciferol; 1alpha-hydroxyvitamin D2; 1-alpha-Hydroxyvitamin D2; 1-alpha-hydroxyergocalciferol; Doxercalciferolum; 3DIZ9LF5Y9; (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; TSA-840; GZ427397; CHEBI:4712; doxacalciferol; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-; 1alpha-OHD2; 1alpha(OH)2D2; 1 alpha-hydroxyergocalciferol; (1R,3S,5Z)-5-((2E)-2-((1R,3aS,7aR)-1-((E,2R,5R)-5,6-dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol; RefChem:56861; H05BX03; (1alpha,3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol; (5Z,7E,22E)-(3S,5R,24S)-9,10-seco-5,7,10(19),22-ergostatetraen-3,24-diol; 1-Hydroxyvitamin D2; TSA 840; MFCD00871065; 1.alpha.-Hydroxyvitamin D2; 1-.alpha.-hydroxyergocalciferol; DTXSID1034214; 1alpha-OH-D2; trans-Doxercalciferol; 1a-Hydroxy Vitamin D2; Doxercalciferol [INN]; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol; (5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3-diol; Hectorol (TN); Vitamin D2, 1alpha-Hydroxy-; 1alpha-hydroxy vitamin D2; UNII-3DIZ9LF5Y9; BRN 4716774; Doxercalciferol [USAN:INN]; 1alphaOHD2; Vitamin Impurity 34; (5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol; 1-alpha-hydroxy-vitamin D2; DOXERCALCIFEROL [MI]; Doxercalciferol (USAN/INN); DOXERCALCIFEROL [USAN]; SCHEMBL322422; 1.alpha.-hydroxyergocalciferol; DOXERCALCIFEROL [VANDF]; GTPL2790; orb1301062; DOXERCALCIFEROL [MART.]; 1-ALPHA-HYDROXYVITAMIND2; CHEMBL1200810; DOXERCALCIFEROL [USP-RS]; DOXERCALCIFEROL [WHO-DD]; HKXBNHCUPKIYDM-CGMHZMFXSA-N; 1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-((2E)-2-((1R,3AS,7AR)-OCTAHYDRO-7A-METHYL-1-((1R,2E)-1,4,5-TRIMETHYL-2-HEXEN-1-YL)-4H-INDEN-4-YLIDENE)ETHYLIDENE)-, (1R,3S,5Z)-; EX-A4428; DOXERCALCIFEROL [ORANGE BOOK]; EBC-27004; HSCI1_000341; LMST03010028; AKOS005146517; CS-0395; DB06410; DOXERCALCIFEROL [USP MONOGRAPH]; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1.alpha.,3.beta.,5Z,7E,22E)-; (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol; (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; BS-17040; HY-32348; 1a-HYDROXYERGOCALCIFEROL (ERCALCIDOL); T6112; C08211; D01009; D82103; EN300-26545978; F804309; Q5303688; 1alpha-hydroxyvitamin D2 / 1alpha-hydroxyergocalciferol; Doxercalciferol, >=98% (HPLC), solubility: >10 mg/mL in DMSO; Doxercalciferol, United States Pharmacopeia (USP) Reference Standard; (5Z,7E,22E)-9,10-SECOERGOSTA-5,7,10(19),22-TETRAENE-1.ALPHA.,3.BETA.-DIOL; 7,10(19),22-TETRAENE-1,3-DIOL,(1-ALPHA,3-BETA,5Z,7E,22E)-10-SECOERGOSTA-5; (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diolSynonymes